Article Versions Notes

De Oliveira T, Goldhardt T, Edelmann M, Rogge T, Rauch K, Kyuchukov ND, Menck K, Bleckmann A, Kalucka J, Khan S, et al. Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo. Cancers. 2021; 13(5):1011. https://doi.org/10.3390/cancers13051011

De Oliveira, Tiago, Tina Goldhardt, Marcus Edelmann, Torben Rogge, Karsten Rauch, Nikola Dobrinov Kyuchukov, Kerstin Menck, Annalen Bleckmann, Joanna Kalucka, Shawez Khan, and et al. 2021. "Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo" Cancers 13, no. 5: 1011. https://doi.org/10.3390/cancers13051011

De Oliveira, T., Goldhardt, T., Edelmann, M., Rogge, T., Rauch, K., Kyuchukov, N. D., Menck, K., Bleckmann, A., Kalucka, J., Khan, S., Gaedcke, J., Haubrock, M., Beissbarth, T., Bohnenberger, H., Planque, M., Fendt, S. -M., Ackermann, L., Ghadimi, M., & Conradi, L. -C. (2021). Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo. Cancers, 13(5), 1011. https://doi.org/10.3390/cancers13051011